These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 35083488)

  • 21. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
    Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
    J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis.
    Wang H; Lu L; Liang X; Chen Y
    Cancer Immunol Immunother; 2022 Jul; 71(7):1757-1769. PubMed ID: 34854950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
    Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
    BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential impact of epithelial splicing regulatory protein 1 (ESRP1) associated with tumor immunity in pancreatic adenocarcinoma.
    Wang P; Gao X; Zheng W; Zhang J
    J Proteomics; 2024 Sep; 308():105277. PubMed ID: 39127164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value and the Immune Microenvironment-associated Role of
    Song Y; Wang Y; Yu T; He Y; Wang C; Wang F; Zhou Y
    Anticancer Res; 2023 Dec; 43(12):5393-5408. PubMed ID: 38030175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovering a Four-Gene Prognostic Model Based on Single-Cell Data and Gene Expression Data of Pancreatic Adenocarcinoma.
    Huang W; Li J; Zhou S; Li Y; Yuan X
    Front Endocrinol (Lausanne); 2022; 13():883548. PubMed ID: 35800432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma.
    Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C
    Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma.
    Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H
    Front Immunol; 2023; 14():1111494. PubMed ID: 36817451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
    Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
    Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.
    Huang X; Zhang G; Tang T; Liang T
    Mol Cancer; 2021 Mar; 20(1):44. PubMed ID: 33648511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
    Yin L; Xiao L; Gao Y; Wang G; Gao H; Peng Y; Zhu X; Wei J; Miao Y; Jiang K; Lu Z
    Med Oncol; 2020 Apr; 37(5):46. PubMed ID: 32277286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological and prognostic values of MET expression in pancreatic adenocarcinoma based on bioinformatics analysis.
    Yao Y; Zhan R; Gong C; Lv J; Lu X
    Medicine (Baltimore); 2023 Oct; 102(41):e34656. PubMed ID: 37832054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma.
    Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R
    BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.
    Su K; Peng Y; Yu H
    Dis Markers; 2022; 2022():9141117. PubMed ID: 35677632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.
    Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G
    BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL5/CXCL8 is a promising potential prognostic and tumor microenvironment-related cluster in hepatocellular carcinoma.
    Zhu J; Zhou Y; Wang L; Hao J; Chen R; Liu L; Li J
    J Gastrointest Oncol; 2020 Dec; 11(6):1364-1380. PubMed ID: 33457007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma.
    Zhu Y; Zhang C; Zhao D; Li W; Zhao Z; Yao S; Zhao D
    Dis Markers; 2021; 2021():7842035. PubMed ID: 34777634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
    Tian C; Li X; Ge C
    Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.